Authors: J C M van der Loo, W P Swaney, E Grassman, A Terwilliger, T Higashimoto, A Schambach, S Hacein-Bey-Abina, D L Nordling, M Cavazzana-Calvoo, A J Thrasher, D A Williams, L Reeves & P Malik (Source: Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
(MedPage Today) — A gene therapy approach to HIV treatment is long-lasting and safe, researchers reported. (Source: MedPage Today Infectious Disease) MedWorm Sponsor Message: Please have a look at this new site driven by MedWorm: The Breast Cancer Daily Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Authors: H Shen, T Sun & M Ferrari (Source: Cancer Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
By Ewen Callaway of Nature magazine [More] Source:http://rss.sciam.com/sciam/topic/gene-therapy
The Advances news section in April's issue of Scientific American included stories on digital textbooks, the promise of using gene therapy to fight blindness and how fragile orchids survive. To learn more about any of the stories, follow these links. [More] Source:http://rss.sciam.com/sciam/topic/gene-therapy
Public release date: 2-May-2012 [ | E-mail | Share ] Contact: Holly Auer holly.auer@uphs.upenn.edu 215-200-2313 University of Pennsylvania School of Medicine PHILADELPHIA — HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. The results provide a framework for the use of this type of gene therapy as a powerful weapon in the treatment of HIV, cancer, and a wide variety of other diseases.
ELK GROVE VILLAGE, Ill., May 2, 2012 (GLOBE NEWSWIRE) — Families of SMA is pleased to announce the award of up to $750,000 for an important new grant to Dr. Brian Kaspar at Nationwide Children’s Hospital.
Academic and industry leaders in gene and cell therapy will be featured at a Media Event in Philadelphia, PA on May 15, 2012, immediately preceding the 15th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) on May 16-19, 2012.Milwaukee, WI (PRWEB) May 02, 2012 Academic and industry leaders in gene and cell therapy will be featured at a Media Event in Philadelphia, PA on May …
The American Society of Gene & Cell Therapy is pleased to honor Dr. David Williams, MD, as the recipient of the Outstanding Achievement Award at the Society’s 15th Annual Meeting on Saturday, May 19th.Milwaukee, WI (PRWEB) May 04, 2012 Pioneering researcher recognized for scientific achievements in gene and cell therapyThe American Society of Gene & Cell Therapy is pleased to honor Dr. David …
PLoS Biology HIV particles assemble at the surface of a white blood cell called a macrophage. Millions of people around the world are living with HIV, thanks to drug regimens that suppress the virus
By Randy Dotinga HealthDay Reporter WEDNESDAY, May 2 (HealthDay News) — New research shows that gene therapy can have long-lasting effects on the immune cells of HIV patients — a promising sign — even though the specific treatment being studied did not eradicate the virus. This approach is one of several gene therapy strategies that are being investigated by scientists as possible ways to keep the AIDS virus from spreading in the blood. In this case, “people were treated by gene therapy and nothing bad happened.
WEDNESDAY, May 2 (HealthDay News) — New research shows that gene therapy can have long-lasting effects on the immune cells of HIV patients — a promising sign — even though the specific treatment being studied did not eradicate the virus.
By Elizabeth Lopatto – Wed May 02 18:00:00 GMT 2012 HIV patients given gene therapy more than a decade ago are healthy and the altered DNA they received remains stable in their bodies, according to a study that scientists say proves the treatment may safely be tested as a way to attack other illnesses. All except two of 43 people treated with genetically- altered versions of their own infection-fighting T cells were healthy as many as 11 years later, according to the research reported today in the journal Science Translational Medicine
BANGALORE, India, April 30, 2012 /PRNewswire/ — I-SMART (Indian Society For Molecular Advanced Regenerative Technologies) a conglomerate of Indian scientists from DRDO, DST, Dr.Agarwal Hospitals, Manacells, Gene Research Foundation has organized the first Gene Therapy Convention to be held at Bangalore on May 2nd 2012.
In this study, CaCO(3) delivering pEGFP-C1-p53 could transfect about 5% of the tumor cells in culture. However, the efficiency of tumor cell apoptosis was surprisingly up to 80%. Meanwhile, the results of MTT assay and crystal violet staining showed that the CaCO(3) microparticles had low cytotoxicity. These findings showed that CaCO(3) microparticles were perspective to [...]
Molecular imaging is revolutionizing the way we study the inner workings of the human body, diagnose diseases, approach drug design, and assess therapies. The field as a whole is making possible the visualization of complex biochemical processes involved in normal physiology and disease states, in real time, in living cells, tissues, and intact subjects. In [...]
Conclusion: These data suggest that rAAV-mediated soluble TRAIL expression under the control of the Tet-On system is a promising strategy for breast cancer therapy. (Source: BMC Cancer)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
ConclusionThese results suggest that epirubicin enhances the antiarthritic effect of rAAV2/5?TRAIL and that combination treatment might be an important therapeutic alternative, with practical significance for rheumatoid arthritis. (Source: Arthritis and Rheumatism)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
In conclusion, adoptive immunotherapy with CD20-specific T cells was well tolerated and was associated with antitumor activity. We will pursue alternative gene transfer technologies and culture conditions in future studies to improve CAR expression and cell production efficiency. This study is registered at www.clinicaltrials.gov as NCT00621452. (Source: Blood) MedWorm Sponsor Message: Please have a look [...]
Authors: T Tang, M H Gao & H Kirk Hammond (Source: Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml